Evidence map›Paper›PMID 42132303›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026

Stereoselective Higher-Order [10+4]- and [10+6] Cycloadditions Between Two Highly Unsaturated and Ambiphilic π-Addends.

Jonas Faghtmann, Anne Kristensen, Fabien Fritz, Signe Sofie Pladsbjerg Andresen, Anne Rask Østergaard, Johannes Nygaard Lamhauge, K N Houk, Karl Anker Jørgensen

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jonas FaghtmannDepartment of Chemistry, Aarhus University, Aarhus C, Denmark.
Anne KristensenDepartment of Chemistry, Aarhus University, Aarhus C, Denmark.
Fabien FritzDepartment of Chemistry, Aarhus University, Aarhus C, Denmark.
Signe Sofie Pladsbjerg AndresenDepartment of Chemistry, Aarhus University, Aarhus C, Denmark.
Anne Rask ØstergaardDepartment of Chemistry, Aarhus University, Aarhus C, Denmark.
Johannes Nygaard LamhaugeDepartment of Chemistry, Aarhus University, Aarhus C, Denmark.
K N HoukDepartment of Chemistry and Biochemistry, University of California, Los Angeles, California, USA.ORCID https://orcid.org/0000-0002-8387-5261
Karl Anker JørgensenDepartment of Chemistry, Aarhus University, Aarhus C, Denmark.ORCID https://orcid.org/0000-0002-3482-6236

Funding

Carlsberg Foundation CF24-2082FNU 2032-00165BNational Science Foundation 2153972Novo Nordisk Fonden 21OC0072047Villum Investigator 25867
6 · The paper itself

Abstract

A fundamental challenge in higher-order cycloadditions (HOCs) is to control multiple layers of selectivity-peri-, regio-, diastereo-, and enantioselectivity. Controlling these selectivities in HOCs is very challenging when they involve two highly unsaturated and ambiphilic π-addends. Here, we study this complexity in enantioselective aminocatalyzed HOCs between isobenzofulvenes, reacting as 10π-components, and 3-oxidopyridinium betaines, reacting as 4π- or 6π-components. The reaction generates three different products: an allowed [10+4] cycloadduct and two forbidden regioisomeric [10+6] cycloadducts. For the [10+6] reaction pathway, the 3-oxidopyridinium betaine reacts as a 6π-component with the fulvene scaffold in unprecedented cycloadditions. The outcome of these cycloadditions exhibits the challenge in controlling the peri- and regioselectivity in complex HOCs involving two highly unsaturated and ambiphilic π-addends. We demonstrate that it is possible to optimize the cycloadditions toward the selective formation of the [10+4] cycloadduct or the [10+6] cycloadducts. Experimental investigations were conducted in combination with DFT calculations, in order to elucidate the origins of these selectivities.

Indexed as

3‐oxidopyridinium betaineasymmetric organocatalysisDFT calculationshigher‐order cycloaddition

Identifiers

PMID42132303
PMCPMC13485177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.